The Pioneer and Leader in New Acute Care Blood Purification
Dr. Phillip Chan, Chief Executive Officer of CytoSorbents
Safe and easy to use
CytoSorb® Therapy has been used more than 200,000 times worldwide in more than 1,000 clinical departments, and its application has been proven to be well-tolerated and safe.
The CytoSorb® adsorber can be used for up to 24 hours after which a change is necessary if the treatment indication persists. Patients have been treated for up to seven consecutive days, for 24 hour periods.
The adsorber is a standard whole blood cartridge and can be used with conventional dialysis and hemofiltration equipment, as well as heart-lung machines, extracorporeal life support machines, or as a stand-alone therapy with blood pumps in hemoperfusion mode. The treatment can be prepared after a short training and can be easily integrated into routine procedures
Evolution
* 01/2012 – 12/2021 pre-clinical and clinical data
in +70 countries
From around the world
Dr. Gabriella Bottari, Italy
Children´s Hospital Bambino Gesù
Dr. Yatin Mehta, India
Medanta Hospital Gurgaon
Prof. Can Ince, The Netherlands
Erasmus Medical Center Rotterdam
Mauro Atti, Italy
Aferetica
Dr. Moritz Fischer, Germany
Fresenius Medical Care
Dr.Tobias Hübner, Schwitzerland
Müsterlinger Cantonal Hospital
Prof. Federico Pappalardo, Italy
National Hospital Alessandria
Celebrate with us
10Years CytoSorb Therapy
CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin
support(at)cytosorbents.com
©2022 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED
*Cytosorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.